Warning Signs After Childbirth That Need Medical Attention (Complete 2026 US Mother’s Guide — CDC Hear Her + ACOG)

Warning signs after childbirth that need medical attention: 2026 US mother’s guide covering postpartum haemorrhage, preeclampsia, DVT, infection, mental health – CDC Hear Her + ACOG. By Dr Sagar Rajkuwar.

How to Eat a Healthy Diet on a Tight Budget in the United States (Complete 2026 Guide — USDA MyPlate + CDC + SNAP)

How to eat a healthy diet on a tight budget in the United States: 2026 USDA MyPlate + CDC-aligned guide. Grocery strategy, batch cooking, SNAP, WIC, 211 resources. $5-$7/day meal planning. By Dr Sagar Rajkuwar.

GLP-1 Medications and Muscle Loss: What Patients Should Know (Complete 2026 US Doctor’s Guide — NIDDK + FDA + NIH)

GLP-1 medications and muscle loss: 2026 US doctor’s guide to lean-mass preservation on Wegovy/Zepbound – protein, resistance training, bimagrumab trials, sarcopenia risk, DEXA monitoring. By Dr Sagar Rajkuwar.

Can You Regain Weight After Stopping Tirzepatide? Complete 2026 US Doctor’s Guide (SURMOUNT-4 + FDA + NIDDK)

Can you regain weight after stopping tirzepatide? Yes — SURMOUNT-4 showed 14 percentage-point regain in 1 year after switching Zepbound to placebo. US doctor’s 2026 guide to prevent regain. By Dr Sagar Rajkuwar.

What Happens When You Stop Taking Semaglutide for Weight Loss? Complete 2026 US Doctor’s Guide (FDA + NIDDK + NIH)

What happens when you stop taking semaglutide for weight loss: appetite returns, gastric emptying normalises, 65% weight regained within a year (STEP-4). Taper, maintenance plan, US coverage. By Dr Sagar Rajkuwar.

GLP-1 Weight-Loss Medications: Benefits, Side Effects and Risks (Complete 2026 US Doctor’s Guide — FDA + NIDDK + NIH)

GLP-1 weight-loss medications: 2026 US doctor’s guide to benefits, side effects, risks, FDA-approved brands (Wegovy, Zepbound, Saxenda), BMI eligibility, costs, insurance. NIDDK + FDA + NIH. By Dr Sagar Rajkuwar.